MDL No. 2244, Northern District of Texas In October 2014, a Dallas jury heard the first of more than 7,000 pending DePuy Pinnacle hip implant cases to be tried. After an 8-week trial and 3 days of deliberation, the jury found for DePuy. Specifically, jurors in the federal court concluded that the Pinnacle implant’s design […]
Last week, on February 3, a jury in Tulsa County, Oklahoma returned a $2.5 million compensatory damage verdict in favor of Plaintiff Andrea Smith against Defendants DePuy Orthopaedics and DePuy International following implantation and subsequent revision surgery of a defective DePuy ASR metal-on-metal hip replacement device. (Smith v. DePuy, CJ-2011-5804, District Court, Tulsa County, Oklahoma) […]
Recently published research reveals that the Food and Drug Administration (FDA) has not done an adequate job at regulating hip replacement systems. As the first trials over Johnson & Johnson’s defective Pinnacle Ultamet hip implant equipment begin across the United States, patients and doctors are left wondering whether these manufacturers were asked to provide evidence […]
Following a long litigation process, DePuy has agreed to a $2.5 billion settlement for its defective ASR XL Acetabular hip replacement and ASR hip resurfacing systems. Roughly 98% of those involved in a mass tort against the company will receive compensation, although those who underwent revision surgery after August 2013 are not included in this […]
This past week a judge in California rejected DePuy Orthopaedics’ attempt to have an $8.3 million injury lawsuit involving the company’s recalled hip implants dismissed. Judge Stephen Czuleger rejected the request for a new trial by Johnson & Johnson’s DePuy subsidiary. Czuleger instead upheld the jury decision reached in March of this year which found […]
Johnson & Johnson’s orthopedic device unit announced this week that it would begin phasing out the production of the all-metal hip devices that have been the source of a multitude of lawsuits in recent years. The announcement was seen as an important move that reflects a trend in the medical device world of moving away […]
Last week the jury in the first DePuy ASR case to go to trial returned a massive $8.3 million verdict to the former prison guard who accused Johnson & Johnsons’ subsidiary of knowingly marketing a faulty hip implant device. Specifically, the jury awarded $338,00 to cover the man’s medical expenses and another $8 million for […]
Just last week we discussed the especially bad week suffered by Johnson & Johnson. Unfortunately, for the medical device company, the bad news appears to keep on coming. The U.S. Food and Drug Administration announced a major Class I recall of yet another Johnson & Johnson orthopedic device. The recall is for a device known […]
In testimony before the jury in the ongoing DePuy ASR hip implant trial, a man testified about how Johnson & Johnson addressed concerns of a marketing executive who had suggested a recall of the metal hips months before the company finally issued the massive recall. The marketing exec sent a series of emails five months […]
In an especially damaging bit of testimony, a surgeon in Montana testified this week that he stopped using the DePuy ASR metal hip implant devices months before the company officially issued its nationwide recall because he was warned about issues with the device by a concerned sales rep. The doctor, Peter Wendt, testified in the […]